| Product No | EMEA/H/C/001106 |
|---|---|
| Brand Name | Elonva |
| Nonproprietary Name | corifollitropin alfa |
| API | corifollitropin alfa |
| ATC Code | G03GA09 |
| Indications | Controlled Ovarian Stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an Assisted Reproductive Technology (ART) program.Elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human Chorionic Gonadotropin (hCG). |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | N.V. Organon |
| Status | Authorised(授权) |
| Authorization Date | 2010-01-25 |
| Version | 23 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information